Politics and Government Politics and Government
Wed, March 12, 2025
Tue, March 11, 2025
Mon, March 10, 2025
Sun, March 9, 2025
Sat, March 8, 2025
[ Sat, Mar 08th ] - Wired
What's Driving Tesla's Woes?
Fri, March 7, 2025
[ Fri, Mar 07th ] - CounterPunch
Cyberpunk Nation
Thu, March 6, 2025
Wed, March 5, 2025
Tue, March 4, 2025

Judge rules against compounding group; Hims' shares fall


//politics-government.news-articles.net/content/ .. -against-compounding-group-hims-shares-fall.html
Published in Politics and Government on Friday, March 7th 2025 at 10:40 GMT by STAT   Print publication without navigation

  • From STAT's Elaine Chen: A federal judge this week ruled against a compounding trade group that wanted to continue making copies of Eli Lilly's obesity drug tirzepatide (sold under the brand names Mounjaro and Zepbound).

The article from STAT News, published on March 7, 2025, discusses several key developments in the biotech industry. It highlights Dr. Marty Makary's testimony at an FDA hearing, where he criticized the agency's handling of the Covid-19 vaccine approval process, suggesting it was rushed and lacked sufficient transparency. Additionally, shares of Hims & Hers Health Inc. surged after the company announced a new telehealth service aimed at providing mental health support. Nimbus Therapeutics received a significant investment to further develop its portfolio, particularly focusing on treatments for autoimmune diseases. Lastly, the article touches on the ongoing debate around the use of Ozempic for weight loss, with new data suggesting potential long-term benefits but also raising concerns about side effects and the drug's availability for diabetic patients.

Read the Full STAT Article at:
[ https://www.statnews.com/2025/03/07/biotech-news-makary-fda-hearing-hims-shares-nimbus-ozempic-the-readout/ ]

Publication Contributing Sources

Similar Politics and Government Publications